Particle.news
Download on the App Store
53 ARTICLES
·
18h ago

White House Launches TrumpRx.gov, a Portal to Discounted Prescription Drugs

The government portal directs cash‑paying patients to manufacturers’ discounts negotiated under most‑favored‑nation pricing.

TrumpRx is a key component of President Donald Trump's efforts to lower drug prices.
US President Donald Trump speaks in the Oval Office of the White House in Washington, DC, US, on Tuesday, Sept. 30, 2025. Pfizer will sell some drugs at a 50% average discount on a direct-to-consumer website called TrumpRx, an initiative intended to allow Americans to pay for prescriptions at discounted rates negotiated by the government.
Image
Image

Overview

  • The site went live Thursday evening and functions as a clearinghouse that links users to drugmakers’ direct‑to‑consumer sites and pharmacy coupons rather than selling medicines itself.
  • The administration says more than a dozen major pharmaceutical companies have signed on under most‑favored‑nation agreements, including Eli Lilly, Novo Nordisk, Pfizer, Merck, Amgen, Gilead, GSK, Sanofi, Novartis, Bristol Myers Squibb, Boehringer Ingelheim, Genentech and EMD Serono.
  • Early examples highlighted by the White House and participating companies include GLP‑1 medicines such as Ozempic and Wegovy priced in the roughly $149–$350 per‑month range and Gilead’s hepatitis C drug Epclusa at $2,425, with more than 40 drugs featured at launch.
  • Experts note the largest savings are likely for uninsured or cash‑pay patients, and purchases routed through TrumpRx generally will not apply to insurance deductibles.
  • Key details remain unclear, including the full drug roster, contract terms and how long discounts will last, and reporting attributes the site’s backend to GoodRx and says some price cuts were exchanged for tariff relief.